Compare ASM & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASM | TNDM |
|---|---|---|
| Founded | 1968 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2005 | 2013 |
| Metric | ASM | TNDM |
|---|---|---|
| Price | $7.53 | $20.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 19 |
| Target Price | $8.18 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 4.4M | 1.8M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,014,736,000.00 |
| Revenue This Year | $53.35 | $8.11 |
| Revenue Next Year | $34.26 | $11.85 |
| P/E Ratio | $67.93 | ★ N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $4.00 | $11.46 |
| 52 Week High | $11.99 | $29.65 |
| Indicator | ASM | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 60.57 | 46.97 |
| Support Level | $5.40 | $19.70 |
| Resistance Level | $8.12 | $20.79 |
| Average True Range (ATR) | 0.38 | 1.11 |
| MACD | -0.02 | -0.40 |
| Stochastic Oscillator | 84.35 | 0.47 |
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.